&w=3840&q=100)
Flu shot must as winter viruses may trigger heart attack or stroke: Study
People who are particularly vulnerable to a heart attack or stroke triggered by a respiratory virus are those with more than one of those traditional risk factors, especially older people
The Conversation
Winter is here, along with cold days and the inevitable seasonal surge in respiratory viruses.
But it's not only the sniffles we need to worry about. Heart attacks and strokes also tend to rise during the winter months.
In new research out this week we show one reason why.
Our study shows catching common respiratory viruses raises your short-term risk of a heart attack or stroke. In other words, common viruses, such as those that cause flu and Covid, can trigger them.
Wait, viruses can trigger heart attacks?
Traditional risk factors such as smoking, high cholesterol, high blood pressure, diabetes, obesity and lack of exercise are the main reasons for heart attacks and strokes.
And rates of heart attacks and strokes can rise in winter for a number of reasons. Factors such as low temperature, less physical activity, more time spent indoors – perhaps with indoor air pollutants – can affect blood clotting and worsen the effects of traditional risk factors.
But our new findings build on those from other researchers to show how respiratory viruses can also be a trigger.
The theory is respiratory virus infections set off a heart attack or stroke, rather than directly cause them. If traditional risk factors are like dousing a house in petrol, the viral infection is like the matchstick that ignites the flame.
For healthy, young people, a newer, well-kept house is unlikely to spontaneously combust. But an older or even abandoned house with faulty electric wiring needs just a spark to lead to a blaze.
People who are particularly vulnerable to a heart attack or stroke triggered by a respiratory virus are those with more than one of those traditional risk factors, especially older people.
What we did and what we found
Our team conducted a meta-analysis (a study of existing studies) to see which respiratory viruses play a role in triggering heart attacks and strokes, and the strength of the link. This meant studying more than 11,000 scientific papers, spanning 40 years of research.
Overall, the influenza virus and SARS-CoV-2 (the virus that causes Covid) were the main triggers.
If you catch the flu, we found the risk of a heart attack goes up almost 5.4 times and a stroke by 4.7 times compared with not being infected. The danger zone is short – within the first few days or weeks – and tapers off with time after being infected.
Catching Covid can also trigger heart attacks and strokes, but there haven't been enough studies to say exactly what the increased risk is.
We also found an increased risk of heart attacks or strokes with other viruses, including respiratory syncytial virus (RSV), enterovirus and cytomegalovirus. But the links are not as strong, probably because these viruses are less commonly detected or tested for.
What's going on?
Over a person's lifetime, our bodies wear and tear and the inside wall of our blood vessels becomes rough. Fatty build-ups (plaques) stick easily to these rough areas, inevitably accumulating and causing tight spaces.
Generally, blood can still pass through, and these build-ups don't cause issues. Think of this as dousing the house in petrol, but it's not yet alight.
So how does a viral infection act like a matchstick to ignite the flame? Through a cascading process of inflammation.
High levels of inflammation that follow a viral infection can crack open a plaque. The body activates blood clotting to fix the crack but this clot could inadvertently block a blood vessel completely, causing a heart attack or stroke.
Some studies have found fragments of the Covid virus inside the blood clots that cause heart attacks – further evidence to back our findings.
We don't know whether younger, healthier people are also at increased risk of a heart attack or stroke after infection with a respiratory virus.
That's because people in the studies we analysed were almost always older adults with at least one of those traditional risk factors, so were already vulnerable.
The bad news is we will all be vulnerable eventually, just by getting older.
What can we do about it?
The triggers we identified are mostly preventable by vaccination.
There is good evidence from clinical trials the flu vaccine can reduce the risk of a heart attack or stroke, especially if someone already has heart problems.
We aren't clear exactly how this works. But the theory is that avoiding common infections, or having less severe symptoms, reduces the chances of setting off the inflammatory chain reaction.
Covid vaccination could also indirectly protect against heart attacks and strokes. But the evidence is still emerging.
Heart attacks and strokes are among Australia's biggest killers. If vaccinations could help reduce even a small fraction of people having a heart attack or stroke, this could bring substantial benefit to their lives, the community, our stressed health system and the economy.
What should I do?
At-risk groups should get vaccinated against flu and Covid. Pregnant women, and people over 60 with medical problems, should receive RSV vaccination to reduce their risk of severe disease.
So if you are older or have predisposing medical conditions, check Australia's National Immunisation Program to see if you are eligible for a free vaccine.
For younger people, a healthy lifestyle with regular exercise and balanced diet will set you up for life. Consider checking your heart age (a measure of your risk of heart disease), getting an annual flu vaccine and discuss Covid boosters with your GP.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India Today
an hour ago
- India Today
From headache to hospitalization: How seasonal flu has changed post-COVID
In the past, the seasonal flu was considered a bothersome condition that resembled the common cold or "fun flu" and was characterized by minor headaches, a mild fever, some body pains, and exhaustion. Since then, the flu's clinical manifestation and/or intensity have evolved. On the other side of COVID, more people show up in hospitals with what appear to be routine flu-like symptoms that rapidly worsen because of serious respiratory issues. Dr. Pratibha Walde, Consultant - Internal Medicine, Manipal Hospital, Kharadi, Pune explains what has changedOur bodies have changed: The body's reaction to influenza viruses, co-infections, and, of course, the long-term consequences of COVID-19 has been altered by post-pandemic immunological sensitivity. A previously healthy people may develop myocarditis (inflammation of the heart tissue), pneumonia, acute respiratory distress syndrome (ARDS), and in certain situations, multi-organ hospitalisations are on the rise: The most at risk will always be elderly people, children, and those with a history of heart problems, diabetes, or asthma. However, the number of hospitalizations for severe flu-related diseases is increasing, especially among younger people without comorbidities. What usually begins as a sore throat or moderate headache can frequently worsen into a high-grade fever, dyspnea, and chest pain, necessitating oxygen therapy or an admission to the intensive care is also requiring more complex intervetions: The rise in instances requiring the procedure or pleural tapping is one of the most alarming trends we have observed. This entails removing contaminated fluid from the pleural space that envelops the lungs. These situations usually occur when the flu causes substantial pleural effusions or an empyema, which is pus in the pleural space. Large pleural effusions and empyema can cause lung collapse, sepsis, or impairment of lung function if left untreated. The probability of needing mechanical ventilation is further impacted by bruised lungs and postponed treatment, particularly if the infection triggered acute respiratory distress syndrome. With a guarded prognosis, recovery from multi-system failures like ARDS can be Early medical attention is crucial: It is necessary to seek medical attention as soon as possible. It has been shown that antiviral drugs such as oseltamivir (Tamiflu) work best when taken during the first 48 hours of symptoms. While rest, hydration, supportive care, and symptom monitoring are important, it's imperative to get medical help if symptoms initial line of defense is still vaccination: The annual flu shot has a new significance in a world where COVID-19 has changed everything. It is for the public as well as those at risk and the elderly. Vaccination can reduce the need for invasive operations and hospital stays when combined with early detection and medical treatment. Seasonal flu is more than just "the flu" these days. The clinical course is more severe and less predictable. Early symptom detection and timely medical evaluation could make the difference between a full recovery and an extended hospital to India Today Magazine


India Today
2 hours ago
- India Today
The B-2 Bomber: Alien tech?
The B-2 bomber: a masterpiece of engineering once rumored to be alien tech. Here's the truth behind the legend. #B2Bomber #UnitedStates #Alien #UFO #Pentagon #Iran #BusterBombs #WorldNews


News18
3 hours ago
- News18
All About The New COVID-19 Variant Causing 'Razor Blade' Sore Throats
Last Updated: The new variant called the NB.1.8.1 has been detected in the US among travellers coming in from Western Pacific nations, with a rising number of patients. The recent spike in coronavirus cases in certain parts of the world has been attributed to a new variant of the virus that caused a global health pandemic, nicknamed the 'razor blade throat" COVID. The variant is called the NB.1.8.1 or 'Nimbus' and causes painful sore throats among those who come into contact. The symptom has been discovered by scientists in India and the United Kingdom, apart from other parts of the world, according to various media outlets. Just when the world was beginning to move on from the horrors of the global health emergency, coronavirus has sprung back into news and discussions with a rising number of affected persons by the new variant. Fever, chills, cough, shortness of breath and loss of taste or smell are proven symptoms of any COVID variant, but Nimbus especially attacks one's throat. While health experts suggest there isn't a cause for major worries about this form of COVID, here is what you need to know about the variant responsible for the sudden spike in global cases. According to a statement dated May 28 by the World Health Organisation, the variant causing the 'razor blade throat' has been spreading primarily in the eastern Mediterranean, Southeast Asia and western Pacific regions. The new variant is responsible for nearly 11% of the global sequenced samples reported since May. In the United States, airport screening held in California, Washington state, Virginia and New York found travellers coming in from those regions affected by the new variant. The new variant is unlikely to cause any worse damage than other variants of the virus that emerged from China in December 2019. Even though Western Pacific countries have reported an increasing number of cases and persons hospitalised, the WHO says there is no proof to suggest the Nimbus variant comes with a disease and symptoms more dangerous than other variants. Likewise, the vaccines proven effective against those variants will help provide relief against NB.1.8.1 as well. The WHO has marked the public health risk from the new variant at a low level, designating it as a 'variant under monitoring" with current vaccinations remaining effective. Last month, Robert F Kennedy Jr announced that COVID-19 injection shots are no longer recommended for healthy children and women undergoing pregnancy. But public health experts raised an immediate question mark on the claim made by the US Health Secretary. First Published: June 22, 2025, 12:37 IST